Penny-Wise, Pound-Foolish Approach May Up Costs in Diabetes – Medscape Medical
Analysis from Medicare claims data from Precision’s Research Economist Joanna MacEwan, PhD at the American Diabetes Association 2015 Scientific Sessions.
By Miriam E. Tucker
BOSTON — Among US Medicare beneficiaries with type 2 diabetes, out-of-pocket expenses diminish adherence to medication and may end up increasing overall healthcare costs in the long run, a new study finds.
Fewer Than Half Of Managed Care Execs Have Access to Health-Record Data They Value – Pharmaceutical Commerce
Precision Advisors is cited in a Pharmaceutical Commerce article focusing on access to EHR data.
Specialty Services for Life Sciences Clients – CEOCFO Magazine
Recently, Dan Renick, Co-President and Chief Commercial Officer, Precision for Medicine spoke with CEOCFO Magazine on the Future of Precision Medicine. Below is an excerpt from the article:
Precision Acquires Precision Health Economics – PharmaVoice
Precision for Medicine’s acquisition of Precision Health Economics is covered in PharmaVoice.
New Push Ties Cost of Drugs to How Well They Work – The Wall Street Journal
Precision for Medicine’s Larry Blandford quoted in today’s Wall Street Journal article: “New Push Ties Cost of Drugs to How Well They Work.” The effort is part of a growing push for so-called pay-for-performance deals amid complaints about the rising price of medications, some of which cost more than $100,000 per patient a year.